Form D — Grace Therapeutics, Inc.
0001140361-25-005827 · filed 2025-02-25
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $30,000,203
- Total sold
- $14,999,985
- Minimum investment
- $1
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Grace Therapeutics, Inc.
- CIK
- 1444192
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 103 Carnegie Center
Princeton, NJ 08540 - Phone
- 609-322-1602
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Prashant Kohli · DirectorPrinceton, NJ Find on LinkedIn ↗
-
Vimal Kavuru · DirectorPrinceton, NJ Find on LinkedIn ↗
-
Robert J. DelAversano · Executive OfficerPrinceton, NJ Find on LinkedIn ↗
-
A. Brian Davis · DirectorPrinceton, NJ Find on LinkedIn ↗
-
S. George Kottayil · DirectorPrinceton, NJ Find on LinkedIn ↗
-
Edward Neugeboren · DirectorPrinceton, NJ Find on LinkedIn ↗
-
Dr. R. Loch Macdonald · Executive OfficerPrinceton, NJ Find on LinkedIn ↗
-
Carrie D'Andrea · Executive OfficerPrinceton, NJ Find on LinkedIn ↗
-
Amresh Kumar · Executive OfficerPrinceton, NJ Find on LinkedIn ↗
View original on SEC EDGAR.